FOLD - Amicus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FOLD is currently covered by 8 analysts with an average price target of $14.99. This is a potential upside of $5.31 (54.86%) from yesterday's end of day stock price of $9.68.

Amicus Therapeutics's activity chart (see below) currently has 95 price targets and 80 ratings on display. The stock rating distribution of FOLD is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.52% with an average time for these price targets to be met of 403.43 days.

Highest price target for FOLD is $21, Lowest price target is $15, average price target is $14.99.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 12-Nov-2024.

Currently out of the existing stock ratings of FOLD, 15 are a BUY (83.33%), 3 are a HOLD (16.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$17

$7.32 (75.62%)

$16

6 days ago
(12-Nov-2024)

6/15 (40%)

$6.47 (61.44%)

454

Buy

$21

$11.32 (116.94%)

$20

11 days ago
(07-Nov-2024)

0/6 (0%)

$10.07 (92.13%)

Buy

$15

$5.32 (54.96%)

$13

1 months 1 days ago
(17-Oct-2024)

2/8 (25%)

$3.03 (25.31%)

578

Buy

$18

$8.32 (85.95%)

$16

2 months 12 days ago
(06-Sep-2024)

2/5 (40%)

$6.31 (53.98%)

371

Buy

$18

$8.32 (85.95%)

$16

5 months 19 days ago
(30-May-2024)

5/7 (71.43%)

$8.12 (82.19%)

233

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FOLD (Amicus Therapeutics) average time for price targets to be met?

On average it took 403.43 days on average for the stock forecasts to be realized with a an average price target met ratio 54.52

Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?

Elemer Piros works at BENCHMARK and has 6 price targets and 6 ratings on FOLD

Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?

Michael Ulz with highest potential upside - $15.32

Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?

Gil Blum with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?